NEW YORK, Dec. 13, 2024 /PRNewswire/ -- An affiliate of the funds known as EQT Infrastructure III and EQT Infrastructure IV ("EQT") is pleased to announce the completion of an underwritten public offering (the "Offering") of 5,500,000 shares of common stock of Kodiak Gas Services, Inc. (NYSE: KGS) (the "Company") for gross proceeds of USD232,925,000. Goldman Sachs & Co. LLC and J.P. Morgan acted as the underwriters for the Offering, which was completed on December 13, 2024. The Company did not sell any shares of its common stock in the Offering and did not receive any proceeds from the sale of the shares of its common stock sold by EQT.

NEW YORK, Dec. 13, 2024 /PRNewswire/ -- An affiliate of the funds known as EQT Infrastructure III and EQT Infrastructure IV ("EQT") is pleased to announce the completion of an underwritten public offering (the "Offering") of 5,500,000 shares of common stock of Kodiak Gas Services, Inc. (NYSE: KGS) (the "Company") for gross proceeds of USD232,925,000. Goldman Sachs & Co. LLC and J.P. Morgan acted as the underwriters for the Offering, which was completed on December 13, 2024. The Company did not sell any shares of its common stock in the Offering and did not receive any proceeds from the sale of the shares of its common stock sold by EQT.

STOCKHOLM, Dec. 13, 2024 /PRNewswire/ -- EQT Exeter, a leading global real estate investment manager, today announced that the EQT Exeter European Logistics Value Fund IV ("EQT Exeter") has acquired two prime logistics properties in Milton Keynes and Dartford from M&G Real Estate. The total transaction price is in excess of GBP 100 million.

STOCKHOLM, Dec. 11, 2024 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Noema Pharma ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland is developing a pipeline of first-in-disease therapeutics that address central nervous system (CNS) disorders. The Series B extension brings the total capital raised in the round to CHF 130 million, including prior investments from Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus and UPMC Enterprises.

STOCKHOLM, Dec. 6, 2024 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the EQT Health Economics strategy has invested in Nua Surgical, an Irish medical device company innovating in maternal health. The €6.5 million Series A financing was led by EQT Life Sciences. The round was also supported by new investors Kidron Capital and the Texas Medical Center (TMC) Venture Fund and existing investors including Enterprise Ireland and business veterans from Ireland and the US. The proceeds will be used to drive the regulatory clearance and early commercialization of the company product, the SteriCISION C-Section Retractor. This innovative device is specifically designed to address the unique challenges of Caesarean-section (C-section) surgery.

STOCKHOLM, Dec. 2, 2024 /PRNewswire/ -- EQT AB's Nomination Committee for the Annual Shareholders' Meeting 2025 has been appointed based on the ownership structure as of 31 August 2024.

The Nomination Committee consists of 

Jacob Wallenberg (Chairperson), appointed by Investor AB Cynthia Lee, appointed by Jean Eric Salata Harry Klagsbrun, appointed by Conni JonssonJoachim Spetz, appointed by Swedbank Robur Funds Conni Jonsson, Chairperson of the Board of EQT AB 

As of 31 August 2024, shareholders having appointed members to the Nomination Committee together represented approximately 29 percent of the voting rights for all shares of EQT AB. 

STOCKHOLM, Dec. 2, 2024 /PRNewswire/ -- The EQT Active Core Infrastructure fund ("EQT") and GIC, a leading global investor, are pleased to announce an agreement to jointly acquire a majority stake in Calisen Group ("Calisen" or "the Company") from funds managed by Global Infrastructure Partners (GIP), a part of BlackRock, the Infrastructure business of Goldman Sachs Alternatives and Mubadala Investment Company. Equitix will remain a minority investor.